Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 22Burkitt Lymphoma 17Central Nervous System Neoplasms 15Neuroblastoma 13Lymphoma, Large B-Cell, Diffuse 13Sarcoma 11Lymphoma, Follicular 11Hodgkin Disease 10Brain Neoplasms 10Medulloblastoma 9Rhabdomyosarcoma 8Wilms Tumor 7Leukemia, Biphenotypic, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large-Cell, Anaplastic 6Oligodendroglioma 5Lymphoma, Mantle-Cell 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Multiple Myeloma 4Malignant mesenchymal tumor 4Dendritic Cell Sarcoma, Interdigitating 4Astrocytoma 4Waldenstrom Macroglobulinemia 3Sarcoma, Ewing 3Rhabdoid Tumor 3Lymphoma, Large-Cell, Immunoblastic 3Ganglioneuroblastoma 3

Interventions

Vincristine 2Radiotherapy 2Radiation 2Magnetic Resonance Spectroscopy 2Dactinomycin 2Cyclophosphamide 2Biopsy 2X-Rays 1Vinorelbine 1Specimen Handling 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma, Embryonal × Vincristine × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT05304585 2026-05-05

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Recruiting
205 enrolled
Sarcoma

Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡